Microbiology News : clinical, Dec 2020

Detect most significant winter viruses on one panel
Differentiate multiple respiratory viruses (SARS-CoV-2, Flu A and B, RSV) in one test without additional workload or costs. Saliva sampling option convenient for patients, do not require extraction and enable a faster, resource-effective workflow, while also achieving high PCR sensitivity. more...
Address the scalability constraints of POC tests with Beckman Coulter’s Access SARS-CoV-2 Antigen assay, offered to healthcare providers at $4, making reliable and frequent mass testing affordable. more...
Co-Diagnostics PCR Test for SARS-CoV-2 variant
Principal design work is now completed for a PCR test that would allow researchers to identify certain mutations in a newly detected variant of SARS-CoV-2 known as VUI 202012/01. more...
Surface Tests for SARS-CoV-2 AOAC validated
bioMérieux's VERIPRO SARS-CoV-2 assay, the PathogenDx EnviroX-Rv assay and the COVID-19 Indoor Test™ by Phylagen are the first three surface tests to receive AOAC Certificate of Validation under its Emergency Response Validation process.  more...
Multiplex RT-qPCR assay for SARS-CoV-2 and Winter viruses
Multiplex assays, ideal for SARS-CoV-2 and winter virus testing, have the potential to save considerable time, effort and reagent use (but are more complex to optimise). Therefore, in a new app note, PCR Biosystems has done the hard work for you. more...
Room Temperature-Stable VTM
Teknova's new Active Viral Transport (ATM) maintains viral (SARS-CoV-2) stability at room temperature for up to 72 hours and can also be stored at room temperature before use and has been tested for USP quality control standards.  more...
RT-PCR KIt for COVID-19 and Flu
EUROIMMUN has announced its new EURORealTime PCR test, which can differentiate between COVID-19 and Flu is now available in countries accepting the CE-mark. This single multiparametric assay can save time & resources in the lab.  more...
Antigen ELISA test for SARS-CoV-2
EUROIMMUN's new ELISA Antigen Test for SARS-CoV-2 has received CE-marking. It has been validated for swab sample material from the upper respiratory tract and demonstrated superior diagnostic accuracy.  more...
IMG Buy BIOLAB
The Innova Medical Group (IMG) has purchased BIOLAB; a California-based CLIA-certified Biosafety Level 2 laboratory. This will allow IMG to streamline testing workflows with accurate and affordable processing. more...
Ellume Over-the-Counter Antigen test for COVID-19
Ellume has received FDA-authorization for its rapid lateral-flow home-test that detects SARS-CoV-2 antigens. The test demonstrated 96% accuracy in a multi-site US clinical study of both adults and children 2 years and above. more...
Rapid Lateral Flow Antigen Test With Enhanced Colours
AccessBio's rapid lateral-flow antigen test for SARS-CoV-2 is now available in the US after receiving FDA authorization. Results are shown clearly on the test due to the NanoAct™ colored cellulose nanobeads embedded in the test strip.  more...
ImmuView P and L urinary antigen test
Bacteria-based diseases present similar symptoms to COVID-19. ImmuView® P&L is the only urinary Antigen Test capable of identifying both Streptococcus pneumoniae and Legionella pneumophila at the same time – with just one test. more...
COVID-19 Saliva Collection Kit
For the collection, transportation, and storage of saliva samples, with stabilized nucleic acid. more...
Rapid Antigen test for COVID-19
Roche's monthly output for its new CE-marked Elecsys SARS-CoV-2 rapid antigen test will be a double-digit million number by 2021. The test returns a result in 18 minutes and runs on the automated cobas e analyzer that can run 300 tests per hour.  more...
Rapid Antigen Self-Test for SARS-CoV-2
A SARS-CoV-2 self-test that uses either stool or sputum specimens is now CE-marked and is currently under evaluation in EC countries. The patent-pending test is a rapid lateral-flow antigen test that utilizes ACE-2 receptors to capture the S-protein of the virus.  more...
Testing for SARS-CoV-2 vaccine immunity - antibodies
Moderna will use the Roche Elecsys® Anti-SARS-CoV-2 S antibody test for its mRNA-1273 vaccine research trials. The test measures quantitative levels of anti-RBD SARS-CoV-2 antibodies and has been authorized by the US FDA. more...
New products for SARS-CoV-2 the coronavirus that causes COVID-19
This week: High-throughput antigen test; Moderna use antibody test to check its vaccine's efficacy; a US FDA-EUA & CE-IVD neutralizing antibody test that detects & quantifies and a novel ACE-2 receptor-based test for home use. more...
Burkholderia cepacia selective agar
Burkholderia cepacia (BCC) is one of the contaminants most frequently encountered in sterile and non-sterile pharmaceutical products.  SGL’s BCC selective media meets the requirements of USP chapter <60> and offers improved isolation of BCC. more...
SARS-CoV-2 Neutralizing antibody test
EKF Diagnostics has announced FDA-EUA and CE-IVD marking for its Kantaro COVID-SeroKlir SARS-CoV-2 IgG antibody test kit that determines both the presence and specific quantities of human IgG antibodies to the SARS-CoV-2 virus.  more...
New products for SARS-CoV-2 the coronavirus that causes COVID-19
This week: Blockchain solution to increase COVID-19 testing in India; ATCC launch external control for testing and Codex DNA have launched a set of SARS-CoV-2 full-length genomes, derivates, and replicons for vaccine and diagnostic development.  more...
COPAN WASP Fully Automated Laboratory
A multicenter study published in the Journal of Clinical Microbiology that evaluated the benefits of COPAN's WASP® and WASPLab® automated solutions has revealed how small to large size laboratories can benefit from changing to a fully automated laboratory.  more...
SARS CoV 2 external controls
ATCC has launched a quality control solution that addresses the critical need for verification and assessment in COVID-19 molecular diagnostic testing for clinical laboratories and test manufacturers. more...
Blockchain for COVID-19 testing supplies
The Tata Group has deployed a blockchain solution for the COVID-19 test reagent shortage problem in India.  The Indian Government will use it as part of their new project to scale up testing to one million tests per day.  more...